Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin-converting Enzyme Inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB) Withdrawal in Patients With Advanced Chronic Kidney Disease

NCT03957161 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03957161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03957161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin-converting Enzyme Inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB) Withdrawal in Patients With Advanced Chronic Kidney Disease
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Withdrawn
Start date
November 30, 2023
Completion date
November 30, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiotensin receptor blockers, angiotensin-converting enzyme inhibitor, blood pressure, chronic kidney disease